You are here:

choriogonadotropin alfa 250 mcg/0.5 ml pre filled syringe (Ovitrelle)


Following an abbreviated submission

choriogonadotropin alfa 250mcg/0.5 ml pre-filled syringe (Ovitrelle) is accepted for use in NHS Scotland for use in women undergoing superovulation prior to assisted reproduction techniques such as in vitro fertilisation, where the use of this preparation is appropriate.

Unlike the vial formulation available previously it does not require reconstitution, and the cost per dose is the same.

This replaces advice previously issued by the Scottish Medicines Consortium for Ovitrelle in May 2006 following a non-submission

Drug Details

Drug Name: choriogonadotropin alfa 250 mcg/0.5 ml pre filled syringe (Ovitrelle)
SMC Drug ID: 263/06
Manufacturer: Serono Ltd
Indication: Superovulation prior to assisted reproductive techniques
BNF Category:
Sub Category: 6.5 Hypothalamic and pituitary hormones and anti-oestrogens
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 9 October 2006

Archived Advice

Non submission 8 May 2006